Skip to main content

Table 1 Demographics and baseline characteristics (ITT population)

From: A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma

Demographic characteristic

Placebo group N = 55

FF 50 QD group N = 56

Total N = 111

Age (years)

 Mean (SD)

8.4 (2.00)

8.4 (1.97)

8.4 (1.97)

 Min., Max.

5, 11

5, 11

5, 11

Age group (years)

 5–< 8

19 (35)

20 (36)

39 (35)

 8–< 12

36 (65)

36 (64)

72 (65)

Sex

 Female

30 (55)

20 (36)

50 (45)

 Male

25 (45)

36 (64)

61 (55)

Height (cm)

 Mean (SD)

134.6 (14.37)

135.3 (15.10)

135.0 (14.68)

 Min., Max.

106, 161

100, 173

100, 173

Weight (kg)

 Mean (SD)

35.88 (14.338)

35.83 (15.054)

35.86 (14.637)

 Min., Max.

18.5, 71.5

17.2, 87.7

17.2, 87.7

  1. Values are n (%), unless otherwise stated, where n represents the number of subjects
  2. FF 50 QD fluticasone furoate 50 µg once daily, ITT intent-to-treat, Min. minimum, Max. maximum, SD standard deviation